Bioactive Scaffold Design for Articular Cartilage Engineering

Author(s):  
Eric Darling ◽  
Kyriacos Athanasiou
2003 ◽  
Vol 85 ◽  
pp. 109-115 ◽  
Author(s):  
MATS BRITTBERG ◽  
LARS PETERSON ◽  
EVA SJÖGREN-JANSSON ◽  
TOMMI TALLHEDEN ◽  
ANDERS LINDAHL

2018 ◽  
Vol 6 (14) ◽  
pp. 2159-2159
Author(s):  
Kirsten Parratt ◽  
Madeline Smerchansky ◽  
Qwantayvious Stiggers ◽  
Krishnendu Roy

Correction for ‘Effect of hydrogel material composition on hBMSC differentiation into zone-specific neo-cartilage: engineering human articular cartilage-like tissue with spatially varying properties’ by Kirsten Parratt et al., J. Mater. Chem. B, 2017, 5, 6237–6248.


2020 ◽  
Vol 106 ◽  
pp. 114-123 ◽  
Author(s):  
Cristina Antich ◽  
Juan de Vicente ◽  
Gema Jiménez ◽  
Carlos Chocarro ◽  
Esmeralda Carrillo ◽  
...  

2016 ◽  
Vol 4 (5) ◽  
pp. 734-767 ◽  
Author(s):  
Sandra Camarero-Espinosa ◽  
Barbara Rothen-Rutishauser ◽  
E. Johan Foster ◽  
Christoph Weder

A summary of the current state of cartilage tissue engineering underlying the relevant biological aspects that are important for scaffold design.


2015 ◽  
Vol 786 ◽  
pp. 257-261
Author(s):  
S. Maidin ◽  
S.E. Shaari

Ostheochondral defects are a lesion on the articular cartilage which happened due to severe twisted knee or a sudden direct impact on the knee during sporting activities. Since, the treatments for this type of injuries which is replacing the articular cartilage with Titanium Alloy has too many disadvantages had caused researchers to develop alternative treatment of scaffolding application. The method of layered manufacturing has allowed AM to be used to produce the scaffold in varying layer of characteristics. Since the injuries of Osteochondral defect have affected many athletes, the scaffold of the articular cartilage has been widely used. However, as the result, there were too many scaffold designs without a clear conscious on what kind of design suits the best. Therefore, a simple program to assist in determining the scaffold design has been developed. It was found that the program was useful to suggest the suitable scaffold design based on the health condition of a patient.


2020 ◽  
Vol 21 (19) ◽  
pp. 7071
Author(s):  
Stefanie Schmidt ◽  
Florencia Abinzano ◽  
Anneloes Mensinga ◽  
Jörg Teßmar ◽  
Jürgen Groll ◽  
...  

Identification of articular cartilage progenitor cells (ACPCs) has opened up new opportunities for cartilage repair. These cells may be used as alternatives for or in combination with mesenchymal stromal cells (MSCs) in cartilage engineering. However, their potential needs to be further investigated, since only a few studies have compared ACPCs and MSCs when cultured in hydrogels. Therefore, in this study, we compared chondrogenic differentiation of equine ACPCs and MSCs in agarose constructs as monocultures and as zonally layered co-cultures under both normoxic and hypoxic conditions. ACPCs and MSCs exhibited distinctly differential production of the cartilaginous extracellular matrix (ECM). For ACPC constructs, markedly higher glycosaminoglycan (GAG) contents were determined by histological and quantitative biochemical evaluation, both in normoxia and hypoxia. Differential GAG production was also reflected in layered co-culture constructs. For both cell types, similar staining for type II collagen was detected. However, distinctly weaker staining for undesired type I collagen was observed in the ACPC constructs. For ACPCs, only very low alkaline phosphatase (ALP) activity, a marker of terminal differentiation, was determined, in stark contrast to what was found for MSCs. This study underscores the potential of ACPCs as a promising cell source for cartilage engineering.


Sign in / Sign up

Export Citation Format

Share Document